In male reproductive system, prostate is one of the major accessory sex gland. As the age increases, under the influence of dihydrotestosterone and testosterone, prostate continue to enlarge. Benign prostatic hyperplasia (BPH) or Benign enlargement of prostate is one of the most common problems of aging males all over the world which causes variety of lower urinary tract symptoms (LUTS). It can lead to simple disturbances in work to severe restriction of day today activities leading to poor quality of life.  BPH starts as early as 40 years of age. The prevalence is greater than 50% by the age of 60 years and by the age of 85years BPH prevalence is as high as 90%. BPH produce wide variety of symptoms which are known as lower urinary tract symptoms (LUTS) which are obstructive and irritative symptoms, also known as voiding and storage symptoms respectively.

Treatment can vary from simple watchful waiting to open prostatectomy. In between the spectrum are medical management with alpha blockers or 5 alpha reductase inhibitors and minimally invasive and endoscopic procedures like Transurethral resection of prostate (TURP), Transurethral needle ablation of prostate (TUNA), transurethral ultrasound–guided laser induced prostatectomy (TULIP), transurethral vaporization of the prostate (TUVP), transurethral incision of prostate (TUIP).

Monopolar TURP is a gold standard and an established procedure and all other procedures are compared with it. With improvement in technology, Bipolar TURP is now increasingly done procedure for benign enlargement because of the advantage of reduced complications. But still monopolar TURP is the most commonly done procedure and is considered as “gold standard”.

The objective of the study is to compare the effectiveness of  monopolar vs bipolar transurethral resection of prostate in the treatment of benign prostatic hypertrophy.

This study will be done in patients requiring surgical intervention for benign prostatic hypertrophy.

Study variables will be resection time required (resection time will be calculated from the period of initiation of resection to the completion of resection), weight of tissues resected using electronic scale. Change in hemoglobin, change in hematocrit and change in the serum electrolyte (it will be compared by using the preoperative values with the values obtained in the immediate post-operative period), improvement in maximum flow rate (Qmax), post void residual urine and IPSS score. (these parameters will be compared by subjecting the patient to uroflowmetry in the pre-operative period and again after one month of intervention to note the change in the maximum urine flow rate and post void residual urine. similarly improvement of IPSS will be compared by asking the patient to fill the IPSS questionnaire preoperatively and at one month postoperative follow up).

The patients will be followed up in the urology department according to the proforma.

Statistical analysis will be done by using IBM SPSS Version 29 for windows. Mean or median score will be calculated based on the disrtribution of scores. T-test will be used as a test of significance for comparing the outcome variables.

      P-value equal to or less than 0.05 will be taken as statistically significant.